RU2007137182A - Микроэмульсии соединений, связывающихся с каннабиноидными рецепторами - Google Patents
Микроэмульсии соединений, связывающихся с каннабиноидными рецепторами Download PDFInfo
- Publication number
- RU2007137182A RU2007137182A RU2007137182/15A RU2007137182A RU2007137182A RU 2007137182 A RU2007137182 A RU 2007137182A RU 2007137182/15 A RU2007137182/15 A RU 2007137182/15A RU 2007137182 A RU2007137182 A RU 2007137182A RU 2007137182 A RU2007137182 A RU 2007137182A
- Authority
- RU
- Russia
- Prior art keywords
- pharmaceutical composition
- composition according
- binds
- surfactant
- cannabinoid receptors
- Prior art date
Links
- 102000018208 Cannabinoid Receptor Human genes 0.000 title claims abstract 10
- 108050007331 Cannabinoid receptor Proteins 0.000 title claims abstract 10
- 239000004530 micro-emulsion Substances 0.000 title claims 5
- 150000001875 compounds Chemical class 0.000 title 1
- 239000000203 mixture Substances 0.000 claims abstract 17
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract 14
- 150000002790 naphthalenes Chemical class 0.000 claims abstract 9
- 239000004094 surface-active agent Substances 0.000 claims abstract 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract 6
- 239000013543 active substance Substances 0.000 claims abstract 6
- RSUMDJRTAFBISX-UHFFFAOYSA-N CB-13 Chemical compound C12=CC=CC=C2C(OCCCCC)=CC=C1C(=O)C1=CC=CC2=CC=CC=C12 RSUMDJRTAFBISX-UHFFFAOYSA-N 0.000 claims abstract 4
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract 4
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 claims abstract 4
- 239000000194 fatty acid Substances 0.000 claims abstract 4
- 229930195729 fatty acid Natural products 0.000 claims abstract 4
- 150000004665 fatty acids Chemical class 0.000 claims abstract 4
- -1 polyoxyethylene Polymers 0.000 claims abstract 3
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 claims abstract 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims abstract 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims abstract 2
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 claims abstract 2
- 239000004359 castor oil Substances 0.000 claims abstract 2
- 235000019438 castor oil Nutrition 0.000 claims abstract 2
- 239000002285 corn oil Substances 0.000 claims abstract 2
- 235000005687 corn oil Nutrition 0.000 claims abstract 2
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 claims abstract 2
- 150000002148 esters Chemical class 0.000 claims abstract 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims abstract 2
- 150000004667 medium chain fatty acids Chemical class 0.000 claims abstract 2
- WSFSSNUMVMOOMR-BJUDXGSMSA-N methanone Chemical compound O=[11CH2] WSFSSNUMVMOOMR-BJUDXGSMSA-N 0.000 claims abstract 2
- 150000003138 primary alcohols Chemical class 0.000 claims abstract 2
- 239000000600 sorbitol Substances 0.000 claims abstract 2
- 239000001069 triethyl citrate Substances 0.000 claims abstract 2
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 claims abstract 2
- 235000013769 triethyl citrate Nutrition 0.000 claims abstract 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims abstract 2
- 239000002609 medium Substances 0.000 claims 6
- 238000000034 method Methods 0.000 claims 5
- 239000003963 antioxidant agent Substances 0.000 claims 4
- 230000003078 antioxidant effect Effects 0.000 claims 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 3
- 239000000654 additive Substances 0.000 claims 3
- 230000000996 additive effect Effects 0.000 claims 3
- 239000004698 Polyethylene Substances 0.000 claims 1
- 239000012736 aqueous medium Substances 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 239000007903 gelatin capsule Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 229920000573 polyethylene Polymers 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 239000002202 Polyethylene glycol Substances 0.000 abstract 1
- 229920001223 polyethylene glycol Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Physical Education & Sports Medicine (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Dispersion Chemistry (AREA)
- Biochemistry (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Otolaryngology (AREA)
- Biomedical Technology (AREA)
- Ophthalmology & Optometry (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0504950.7A GB0504950D0 (en) | 2005-03-10 | 2005-03-10 | Organic compositions |
| GB0504950.7 | 2005-03-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2007137182A true RU2007137182A (ru) | 2009-10-20 |
Family
ID=34508852
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2007137182/15A RU2007137182A (ru) | 2005-03-10 | 2006-03-10 | Микроэмульсии соединений, связывающихся с каннабиноидными рецепторами |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20080279940A1 (https=) |
| EP (3) | EP2065033A1 (https=) |
| JP (1) | JP2008532967A (https=) |
| KR (1) | KR20070117578A (https=) |
| CN (1) | CN101137348A (https=) |
| AU (1) | AU2006222117B2 (https=) |
| BR (1) | BRPI0609023A2 (https=) |
| CA (1) | CA2599251A1 (https=) |
| GB (1) | GB0504950D0 (https=) |
| MX (1) | MX2007011016A (https=) |
| RU (1) | RU2007137182A (https=) |
| WO (1) | WO2006094829A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0907805A2 (pt) * | 2008-02-28 | 2015-07-14 | Novartis Ag | Combinações para tratar dor associada à hiv |
| JO3337B1 (ar) | 2010-12-13 | 2019-03-13 | Debiopharm Sa | تركيبات صيدلية تشمل أليسبوريفير |
| US10350165B2 (en) * | 2014-12-12 | 2019-07-16 | Ojai Energetics Pbc | Methods and systems for forming stable droplets |
| MX385464B (es) * | 2014-12-12 | 2025-03-18 | Ojai Energetics Pbc | Composiciones microencapsuladas de cannabinoides |
| GB2551987A (en) | 2016-07-01 | 2018-01-10 | Gw Res Ltd | Oral cannabinoid formulations |
| GB2551986A (en) | 2016-07-01 | 2018-01-10 | Gw Res Ltd | Parenteral formulations |
| IL248149B (en) * | 2016-09-29 | 2020-03-31 | Garti Nissim | Dilutable formulations of cannbinoids and processes for their preparation |
| IL248150B (en) * | 2016-09-29 | 2018-05-31 | Garti Nissim | Method for selective extraction of cannabinoids from a plant source |
| IL248148B (en) | 2016-09-29 | 2021-09-30 | Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd | A method for extracting a compound from plant origin |
| GB2559774B (en) | 2017-02-17 | 2021-09-29 | Gw Res Ltd | Oral cannabinoid formulations |
| GB2569961B (en) * | 2018-01-03 | 2021-12-22 | Gw Res Ltd | Pharmaceutical |
| WO2024033521A1 (en) | 2022-08-12 | 2024-02-15 | GW Research Limited | Oral solid dosage forms comprising cannabinoids |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1274354A (fr) | 1956-03-10 | 1961-10-27 | Agents tensio-actifs obtenus à partir de triglycérides et polyéthylène glycol | |
| GB2222770B (en) * | 1988-09-16 | 1992-07-29 | Sandoz Ltd | Pharmaceutical compositions containing cyclosporins |
| GB9113872D0 (en) | 1991-06-27 | 1991-08-14 | Sandoz Ag | Improvements in or relating to organic compounds |
| FR2697040B1 (fr) | 1992-10-21 | 1994-12-30 | Ind Entreprise | Elément de protection contre le bruit et son utilisation. |
| PE52896A1 (es) | 1994-10-26 | 1996-12-12 | Novartis Ag | Composicion farmaceutica |
| US6294192B1 (en) * | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
| GB0008785D0 (en) * | 2000-04-10 | 2000-05-31 | Novartis Ag | Organic compounds |
| GB0012795D0 (en) * | 2000-05-25 | 2000-07-19 | Novartis Ag | Organic compounds |
| US6623765B1 (en) * | 2000-08-01 | 2003-09-23 | University Of Florida, Research Foundation, Incorporated | Microemulsion and micelle systems for solubilizing drugs |
| GB0028702D0 (en) * | 2000-11-24 | 2001-01-10 | Novartis Ag | Organic compounds |
-
2005
- 2005-03-10 GB GBGB0504950.7A patent/GB0504950D0/en not_active Ceased
-
2006
- 2006-03-10 MX MX2007011016A patent/MX2007011016A/es not_active Application Discontinuation
- 2006-03-10 BR BRPI0609023-0A patent/BRPI0609023A2/pt not_active IP Right Cessation
- 2006-03-10 US US11/908,216 patent/US20080279940A1/en not_active Abandoned
- 2006-03-10 EP EP09151789A patent/EP2065033A1/en not_active Withdrawn
- 2006-03-10 KR KR1020077020512A patent/KR20070117578A/ko not_active Withdrawn
- 2006-03-10 CN CNA2006800076288A patent/CN101137348A/zh active Pending
- 2006-03-10 CA CA002599251A patent/CA2599251A1/en not_active Abandoned
- 2006-03-10 EP EP06723358A patent/EP1858484A1/en not_active Withdrawn
- 2006-03-10 RU RU2007137182/15A patent/RU2007137182A/ru not_active Application Discontinuation
- 2006-03-10 WO PCT/EP2006/002245 patent/WO2006094829A1/en not_active Ceased
- 2006-03-10 JP JP2008500134A patent/JP2008532967A/ja active Pending
- 2006-03-10 EP EP10178526A patent/EP2305215A1/en not_active Withdrawn
- 2006-03-10 AU AU2006222117A patent/AU2006222117B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| GB0504950D0 (en) | 2005-04-20 |
| AU2006222117A1 (en) | 2006-09-14 |
| KR20070117578A (ko) | 2007-12-12 |
| CA2599251A1 (en) | 2006-09-14 |
| EP2065033A1 (en) | 2009-06-03 |
| CN101137348A (zh) | 2008-03-05 |
| AU2006222117B2 (en) | 2010-06-03 |
| US20080279940A1 (en) | 2008-11-13 |
| BRPI0609023A2 (pt) | 2010-01-12 |
| JP2008532967A (ja) | 2008-08-21 |
| MX2007011016A (es) | 2007-09-26 |
| EP2305215A1 (en) | 2011-04-06 |
| EP1858484A1 (en) | 2007-11-28 |
| WO2006094829A1 (en) | 2006-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2012120388A (ru) | Фармацевтические композиции, включающие производное камптотецина | |
| JP2013508296A5 (https=) | ||
| JP5057610B2 (ja) | 自然分散性ｎ−ベンゾイルスタウロスポリン組成物 | |
| JP2006514119A (ja) | 溶解率が向上した難溶性薬剤の溶媒系 | |
| RU2007137182A (ru) | Микроэмульсии соединений, связывающихся с каннабиноидными рецепторами | |
| JP2002510329A (ja) | 親油性化合物用の自己乳化性処方 | |
| WO2002053131A1 (fr) | Compositions pharmaceutiques colloïdales micellaires renfermant un principe actif lipophile | |
| SK285471B6 (sk) | Farmaceutické prostriedky obsahujúce cyklosporín | |
| KR101025641B1 (ko) | 매스틱 자가유화에멀젼 조성물 및 이를 함유하는 캡슐 | |
| AU2014222389A1 (en) | A composition comprising a lipid compound, a triglyceride, and a surfactant, and methods of using the same | |
| JP2017503866A (ja) | デュタステリドを含む自己乳化型薬物送達システムのための組成物 | |
| JP2008532967A5 (https=) | ||
| EP0277352B1 (de) | Synergistische Kombination von Azelastin und Theophyllin oder Azelastin und Beta-Mimetika | |
| BE1012143A5 (fr) | Nouvelles compositions pharmaceutiques. | |
| CN105640961A (zh) | 一种含依鲁替尼的药物组合物 | |
| KR20130115650A (ko) | ４－［５－（４－메칠페닐）－３－（트리플루오로메칠）피라졸－１－일］벤젠술폰아미드 화합물 함유 액상 조성물 | |
| KR101612257B1 (ko) | 고농도의 탁산을 포함하는 경구 투여용 약학 조성물 | |
| JP6580305B2 (ja) | 外用医薬組成物 | |
| WO2000051563A1 (fr) | Compositions pharmaceutiques pour l'administration orale comprenant un benzamide et au moins un promoteur d'absorption | |
| RU2025102043A (ru) | Фармацевтические композиции, содержащие изотретиноин, и способы их получения и применения | |
| JP6599083B2 (ja) | 外用医薬組成物 | |
| JP2005075804A (ja) | メナテトレノン含有医薬組成物 | |
| RU2021134823A (ru) | Композиции жидкой пероральной лекарственной формы метилналтрексона | |
| RU2000125560A (ru) | Предварительно приготовленные эмульсионные концентраты, содержащие циклоспорин или макролид | |
| WO2009095560A1 (fr) | Compositions pharmaceutiques a base de derives d´azetidine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20110224 |